1. FRI0256 Long-term safety of tocilizumab in patients with rheumatoid arthritis following a mean treatment duration of 3.9 years. (23rd January 2014) Authors: Genovese, M.; Sebba, A.; Rubbert-Roth, A.; Scali, J.; Alten, R.; Kremer, J.; Pitts, L.; Vernon, E.; van Vollenhoven, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0228 EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB (SPIRIT-H2H) WITH AND WITHOUT CONCOMITANT CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN BIOLOGIC DMARD-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS: 52-WEEK RESULTS. (2nd June 2020) Authors: Smolen, J. S.; Sebba, A.; Ruderman, E.; Gellett, A.; Sapin, C.; Sprabery, A. T.; Liu Leage, S.; Pillai, S.; Reis, P.; Nash, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0102 NONINFLAMMATORY PAIN IS A FREQUENT PHENOMENON IN RHEUMATOID ARTHRITIS AND RESPONDS WELL TO TREATMENT WITH SARILUMAB. (2nd June 2020) Authors: Choy, E.; Bykerk, V.; Lee, Y.; St John, G.; Van Hoogstraten, H.; Ford, K.; Praestgaard, A.; Sebba, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0121 PAIN AND OTHER PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO DID OR DID NOT ACHIEVE TREATMENT RESPONSE BASED ON IMPROVEMENT IN SWOLLEN JOINTS IN TOCILIZUMAB CLINICAL TRIALS. (2nd June 2020) Authors: Sebba, A.; Han, J.; Mohan, S. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗